🇮🇪·6d agoCRO
Liquid biopsy and the future of tumour-agnostic treatments
Publisher
I
ICON plc
Ireland
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- ICON plc
- Region
- Ireland
- Scope
- CRO
- Published
- June 24, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on iconplc.com
Leave the platform to read the original full article on the publisher site.
Source: ICON plc
Scope: CRO
Related coverage
More related coverage
openFDA Drug Labels/-404m ago
Drug label update: Evereden Kids Mineral Sunscreen SPF 30
Official structured record identifier: bba219a4-de83-76fd-e053-2995a90a2d69.
openFDA Drug Labels/-404m ago
Drug label update: GUNA-VIRUS
Official structured record identifier: 53e741c4-8897-71f3-e063-6394a90a751d.
UNLP Health Sciences/55m ago
Artrosis canina: desarrollan un tratamiento a base de cartílago de tiburón
Advarra (IRB)/1h ago